retatrutide new england journal of medicine Promises Big Weight Loss, but Safety Remains a Question Retatrutide is generating a lot

Watch for any reaction: redness lasting more than 30 minutes, itching, burning, breakouts in treated areas, or increased skin sensitivity to other products or environmental factors

(Note: compounded medications are not FDA-approved.) Sources Medscape: Are Sexual Side Effects Emerging With GLP-1 Agonists

10.1007/s11892-018-0976-6 299 SchliessF.Von DahlS.HaussingerD

Soon after the FDAs approval of the new use for Wegovy, the Centers for Medicare & Medicaid Services (CMS) issued a memo indicating that Medicare Part D plans can add Wegovy to their formularies now that it has a medically-accepted indication that is not specifically excluded from Medicare coverage